title: Mechanism of crosstalk inhibition of IL-6 signaling in response to LPS and TNFalpha.
abstract: Negative regulation of cytokine signaling is critical for the generation of the appropriate cellular outcome in response to signals, and can be modulated by other concomitant extracellular stimuli ("crosstalk"). Using both genetic and pharmacological manipulations we have investigated the mechanisms by which the pro-inflammatory stimuli, lipopolysaccharide (LPS) and Tumor necrosis factor alpha (TNFalpha), negatively regulate interleukin-6 (IL-6) signaling in primary mouse macrophages. Analysis of suppressor of cytokine signalling 3 (SOCS3)-deficient macrophages reveal that SOCS3 is necessary but surprisingly, not sufficient for the complete crosstalk inhibition of IL-6 signaling induced by LPS and TNFalpha. Analysis of macrophages from gp130 (Y757F) mutant mice suggest that SH2 domain-containing tyrosine phosphatase (SHP2) activity does not explain the residual inhibitory effect of these pro-inflammatory stimuli. In addition, p38 mitogen-activated protein kinase (p38) activation also negatively regulates IL-6 signaling independent of its parallel and necessary action to induce SOCS3 expression. Finally, we have identified an additional, novel mechanism of crosstalk inhibition: a reduction in total cellular levels of gp130 following stimulation with LPS and TNFalpha.
authors.affiliation: Division of Cancer and Hematology, The Walter and Eliza Hall Institute of Medical Research, Parkville, Vic., Australia.
authors.forename: Hiu
authors.initials: H
authors.lastname: Kiu
authors.forename: Douglas J
authors.initials: DJ
authors.lastname: Hilton
authors.forename: Nicos A
authors.initials: NA
authors.lastname: Nicola
authors.forename: Matthias
authors.initials: M
authors.lastname: Ernst
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Marquez
authors.forename: Warren S
authors.initials: WS
authors.lastname: Alexander
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Roberts
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Mcmanus
mesh_terms: D000818:Animals; D050822:Cytokine Receptor gp130 / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D015398:Signal Transduction / Q000187:drug effects; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D015850:Interleukin-6; D008070:Lipopolysaccharides; C491411:Socs3 protein, mouse; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins; D014409:Tumor Necrosis Factor-alpha; D050822:Cytokine Receptor gp130; D048051:p38 Mitogen-Activated Protein Kinases